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Alzheimer’s disease (AD) is an irreversible and progressive neurodegenerative disorder with no known cure or clear under-
standing of the mechanisms involved in the disease process. Amyloid plaques, neurofibrillary tangles and neuronal loss, 
though characteristic of AD, are late stage markers whose impact on the most devastating aspect of AD, namely memory loss 
and cognitive deficits, are still unclear. Recent studies demonstrate that structural and functional breakdown of synapses may 
be the underlying factor in AD-linked cognitive decline. One common element that presents with several features of AD is 
disrupted neuronal calcium signaling. Increased intracellular calcium levels are functionally linked to presenilin mutations, 
ApoE4 expression, amyloid plaques, tau tangles and synaptic dysfunction. In this review, we discuss the role of AD-linked 
calcium signaling alterations in neurons and how this may be linked to synaptic dysfunctions at both early and late stages of 
the disease. 
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1  Alzheimer’s disease and the relevance of 
synaptic dysfunction 
Alzheimer’s disease (AD) is a devastating neurodegenera-
tive disorder that gradually and insidiously destroys neurons, 
leading to cognitive, memory and behavior impairments. 
AD is definitively diagnosed through patient history of cog-
nitive decline in conjunction with postmortem findings of 
amyloid beta (Aβ) plaques, neurofibrillary tau tangles and 
extensive neuronal loss in the hippocampus and neocortex. 
The most common form, termed sporadic AD, has a rela-
tively late age of onset (>65 years of age), though its etiol-
ogy remains a mystery. The inherited or familial form (FAD) 
exhibits a similar pattern of cognitive decline and histo-
pathology, though the progression of symptoms is far more 
aggressive and the age of onset is markedly younger (30–40 
years). FAD is linked to mutations in the amyloid precursor 
protein (APP) and the presenilin (PS) 1 and 2 genes. While 
the mechanistic link between the development of AD and 
these gene mutations is unclear, their expression will invar-
iably lead to AD [1,2].  
The amyloid beta peptide, the primary component of 
plaques, is derived from altered processing of the amyloid 
precursor protein (APP). Sequential cleavage of APP by β- 
and γ-secretases results in production of Aβ peptides–the 
more common Aβ40 and the pathogenic Aβ42. Presenilin 
forms the catalytic core of the γ-secretase enzyme complex 
and regulates the intramembranous cleavage of APP to 
Aβ. The majority of presenilin gene mutations studied in 
model systems have been shown to alter γ-secretase cleav-
age of APP, resulting in increased production of the toxic 
Aβ42 [2–4]. These same presenilin mutations have also been 
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linked to altered intracellular calcium signaling in a variety 
of model and cell systems, and will be the subject of further 
discussion later in this review.  
Despite being an obligatory diagnostic feature of AD, Aβ 
and tau deposits are poorly correlated with the most devas-
tating aspect of AD, namely the progressive memory loss 
and cognitive decline. In fact, both Aβ plaques and tau tan-
gles are present in the hippocampus and neocortex of indi-
viduals without cognitive deficits or dementia, at levels 
similar to those found in individuals with dementia [5–8]. 
More recent and convincing evidence implicates the break-
down of synaptic integrity and function as a better correlate, 
and likely causative agent, of cognitive decline in AD 
[9–14]. These studies demonstrate not only neuronal loss 
but a reduction in dendritic arborization and dendritic spine 
density of pyramidal neurons in AD patients and animal 
models. Indeed, AD has increasingly been referred to as a 
“synaptic disease” because of the central role synaptic 
breakdown has in the devastating cognitive deficits of the 
disease [10,15–17]. Although this review will focus on the 
proximal role calcium dysregulation has in promoting syn-
aptic dysfunction in AD, it also is worth noting that other 
hallmark, but not exclusive, features of AD such as Aβ and 
hyperphosphorylated tau, also introduce synaptic pathology 
(as well as calcium dysregulation) [18–21]. It is likely that 
the combined, feed-forward pathogenic cascades among 
these features will accelerate the demise of synapses in AD, 
though independently each can result in dysfunction.   
There are several reasons why synaptic impairment is of 
principal significance to cognitive loss in AD. One of the 
observations in the brains of AD patients is a reduction in 
the number of dendritic spines and their connections with 
presynaptic terminals to anchor a functional synapse [11–14]. 
Structurally, the dendrites of pyramidal neurons are covered 
with numerous spines, or protrusions, that serve as the 
postsynaptic sites for most excitatory synapses. Within the-
se small compartments (~0.01 to 0.8 µm3), an extensive 
array of cellular machinery is condensed which supports a 
unique signaling microcosm of receptors, scaffolding pro-
teins, second messengers, kinases/phosphatases, gene tran-
scription factors and immediate early genes, and, among 
other signaling factors, calcium [22,23]. Here, calcium 
serves many functions, but the common denominator is its 
role in transducing and modifying neurochemical signals 
released from presynaptic terminals into electrical gradients 
(such as through voltage-gated calcium channels, and cal-
cium-permeable postsynaptic receptors), and promoting 
downstream signaling cascades by activating calcium-  
sensitive kinases, phosphatases, and the like [24,25]. Be-
cause of the unique geometry of the spine head and neck, 
which confers a high resistance barrier to the adjacent den-
dritic process, the spine head signaling domain is protected 
to maintain proper synaptic transmission and plasticity 
properties, which in turn can support learning and memory 
functions within key brain regions [22,23]. Therefore, lo-
calized calcium signals in dendritic spines and processes are 
central to proper neuronal activity and synaptic functioning, 
and sustained calcium dyshomeostasis can alter both the 
structural and functional aspects of the spine apparatus 
[26,27]. This can occur in either the absence of amyloid or 
tau histopathology, or, become greatly accelerated in the 
presence of misfolded protein aggregates.  
2  AD pathology, risk factors, and mechanisms 
of early calcium dyshomeostasis 
Maintenance of intracellular calcium homeostasis is essen-
tial for the functioning and survival of neurons and is a 
fundamental component of synaptic transmission for both 
pre- and postsynaptic mechanisms [28,29]. Given the crucial 
and widespread roles calcium signaling has in excitable 
cells, it is not surprising that alterations in calcium homeo-
stasis are linked to several neurodegenerative conditions 
[30–33]. Calcium concentrations in the cytosol are typically 
maintained at nanomolar levels but can locally be increased 
to micromolar levels within distinct microdomains such as 
outside channel pore regions and within enclosed domains 
such as spine heads [22,34]. Cytosolic calcium entry is pre-
dominantly mediated by ligand-gated channels (such as 
NMDA receptors) or voltage-gated calcium channels 
(VGCC) located in the plasma membrane. Release of cal-
cium from intracellular ER sources occurs via ER mem-
brane channels–inositol trisphosphate receptor (IP3R) and 
ryanodine receptor (RyR). The IP3Rs are activated by the 
second messenger IP3 while the RyRs are activated by cy-
tosolic calcium. The activation of both of these channels is 
augmented by the phenomenon of calcium-induced calcium 
release (CICR) a regenerative process in which calcium 
enhances its own release from IP3R and RyR. This 
self-limiting dynamic enables the recruitment of ER calci-
um through a variety of calcium signaling pathways in neu-
ronal physiology, serving in part as a coincidence detector 
across calcium sources. For instance, RyR-mediated CICR 
can be augmented by calcium entering through plasma 
membrane calcium channels as well as calcium released 
through the IP3R [35–37]. Mitochondrial calcium dynamics 
make a relatively smaller contribution, but are still an im-
portant component in regulating calcium homeostasis by 
quickly taking up excess calcium released from ER stores 
and slowly releasing it in the cytosol [38].  
Aberrant neuronal calcium signaling is increasingly im-
plicated as a pathogenic factor in AD and is also observed 
with sporadic AD risk factors such as ApoE 4 expression 
and CALHM1 polymorphisms (Figure 1). The calcium 
dyshomeostasis resulting from AD-linked PS mutations, as 
well as presumed ApoE4 expression and CALHM poly-
morphisms, is present throughout the organism’s lifetime 
[32,39,40]. This is in contrast to the emergence of amyloid 
plaques and tau tangles relatively late in one’s lifetime-in 
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both neurodegenerative disease states and as a part of nor-
mal aging. In familial and sporadic AD associated with ge-
netic risk factors, the long-term exposure to genetic aberra-
tions suggests that either cumulative lifelong challenges, or 
predisposing vulnerabilities to age-dependent or epigenetic 
insults, may contribute to the pathology resulting in AD. 
However, identifying the actual early pathogenic mecha-
nisms has thus far been elusive save for increased ER cal-
cium linked to PS mutations.  
The effects of PS mutations on calcium dysregulation 
have been demonstrated in model cell systems, namely 
transgenic mice and human cells [41–46]. Several mecha-
nisms have been proposed for the effects of mutant PS on 
ER calcium signaling. One hypothesis suggests that PS, in 
its wild-type state, may function as an ER leak channel that 
maintains ER calcium homeostasis by releasing calcium and 
balancing SERCA (Sarco/Endoplasmic Reticulum Calcium 
ATPase) pump activity. Mutant PS may be impaired as a 
leak channel, and as a result, ER calcium stores become 
overfilled which can introduce homeostatic changes in RyR 
expression, protein misfolding, and other downstream con-
sequences [47,48]. Direct alterations of IP3R function have 
also been documented. Mutant PS1 has been shown to in-
crease the open probability of the IP3R and to shift modal 
gating properties to bursts of repetitive openings at what 
would normally be sub-threshold IP3 concentrations, result-
ing in net increased ER calcium release through these 
channels [49,50]. Consistent with this, within the soma of 
mutant PS1-expressing neurons, baseline circulating levels 
of cytosolic IP3 are sufficient to generate a modest 
IP3-evoked calcium response in the presence of elevated 
calcium (a necessary co-agonist at the IP3R), whereas in 
control neurons, this low-level [IP3] is insufficient to acti-
vate the IP3R [16].  
There are also several lines of evidence demonstrating 
effects of mutant PS on RyR-mediated calcium release and 
CICR threshold. In mutant PS-expressing animal models, 
increased RyR-mediated calcium release is observed before 
the histopathological and cognitive symptoms emerge and 
persists throughout the organism’s lifetime [46,51]. Addi-
tionally, conditions which result in increased ER calcium 
levels can further enhance RyR responsivity to cytosolic 
calcium [52,53], thereby augmenting CICR and establishing 
a long-term feed-forward mechanism of calcium cycling. 
Direct modulation of RyR by PS may be one concrete 
mechanism by which ER calcium dyshomeostasis results. 
The PS1 N-terminal domain is thought to bind to and poten-
tiate RyR calcium flux, and under normal conditions, the 
degree of calcium release is kept within physiological limits 
by a calcium-dependent negative feedback mechanism by 
which the RyR detects elevated calcium and subsequently 
suppresses further calcium release [54]. Mutant PS1 may 
impair this feedback function whereby RyR activity persists 
even at high calcium concentration. There is also evidence 
that PS1 mutations increase ryanodine receptor (RyR) ex-
pression levels in neurons [46,51,55], with distinct isoform 
specific patterns. At early or presymptomatic stages, the 
RyR2 isoform is selectively upregulated and may underlie 
the exaggerated RyR-evoked calcium responses and sensi-
tized CICR, while at later stages, coincident with Aβ42 dep-
osition, RyR3 levels upregulate in what is possibly a neuro-
protective response [16,56–58]. The RyR2 is densely ex-
pressed in several brain regions vulnerable in AD, especial-
ly the hippocampus, while the RyR3 expression patterns are 
typically more diffuse and relatively sparse [59,60]. Notably, 
increased RyR2 expression is also observed in individuals 
with mild cognitive impairment (MCI), which is thought to 
be an early stage of dementia that ultimately will convert to 
AD [61].  
Resulting from this preexisting calcium dysregulation, a 
subsequent pathogenic cascade may develop between in-
creased calcium levels and Aβ deposition in AD. Aβ oli-
gomers may increase calcium influx by forming calcium 
pores in the plasma membrane and by regulating existing 
plasma membrane calcium channels [62–64]. Increased 
intracellular calcium, and more specifically, RyR-mediated 
calcium release, can in turn facilitate the formation of path-
ogenic Aβ peptides and plaque aggregation [65–67], and 
equally increasing Aβ load can increase RyR3 expression 
[57]. An analogous facilitatory pathogenic relationship may 
exist between calcium signaling and tau pathology. In-
creased intracellular calcium potentiates neurofibrillary tan-
gle formation by upregulating the activity of calci-
um-dependent tau kinases such as glycogen synthase kinase 
3β, protein kinase C, cdk5 and others [68]. Conversely, hy-
perphosphorylated tau can further raise intracellular calcium 
concentrations by compromising the integrity of neuronal 
processes, altering signaling cascades, and upregulating 
cholinergic receptor activation coupled to calcium release 
[32].  
The known sporadic AD risk factors such as CALHM1 
and ApoE4 allele expression also alter intracellular calcium 
levels. The CALHM1 gene encodes a transmembrane cal-
cium permeable channel which is inserted in ER and plasma 
membranes. Recently, a polymorphism of CALHM1 was 
found that is associated with increased AD risk, increasing 
Aβ deposition by altering calcium permeability [40]. 
Apolipoprotein E (ApoE) is a lipid-associated protein in-
volved in transport of lipids. There are three ApoE alleles, 
ApoE2, ApoE3 and ApoE4, each conferring distinct vul-
nerability to AD. Expressing ApoE2 is considered neuro-
protective, while E4 expression is linked to increased risk of 
AD [69,70]. ApoE4 increases intracellular calcium levels 
via a cell-surface LDL receptor-mediated process that re-
cruits plasma membrane calcium channels as well as 
RyR-mediated ER stores [32]. Further, ApoE4 is found in 
close proximity to amyloid plaque, suggesting that it may 
play a role in Aβ formation and in a larger pathogenic pro-
cess involving lipid metabolism, calcium, and protein fold-
ing [71]. 
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Figure 1  Convergent and enabling pathways for calcium involvement in the early pathogenesis of AD. Extracellular calcium influx through the plasma 
membrane or release from ER stores may be capable of inducing or facilitating several cardinal features of late-stage AD. These features in turn, can further 
increase ER calcium release, supporting a feedforward pathological cycle, resulting in gradually accumulating cellular insults. Ultimately, the cellular com- 
pensatory mechanisms may become overwhelmed and give way to pathological signaling cascades. (Reprinted with permission from Stutzmann, 2007). 
3  Calcium channels, neurotransmission and 
synaptic plasticity 
The dynamic interplay between calcium sources becomes 
particularly relevant when considering pre and postsynaptic 
mechanisms underlying neurotransmission and synaptic 
plasticity (Figure 2) [28,72–75]. Presynaptically, ER calci-
um mediates neurotransmitter release via coupling of cal-
cium binding sensors to neurotransmitter vesicles. CICR 
through the RyR may trigger spontaneous neurotransmitter 
release that is detected as miniature postsynaptic potentials 
[76,77]. When presynaptic calcium levels are elevated in 
response to an action potential, the immediately releasable 
pool of neurotransmitter vesicles is released into the synap-
tic cleft. This is followed by a slow calcium-dependent 
phase during which the readily releasable pool is replen-
ished from a reserve pool. CICR evoked by voltage-    
dependent calcium entry can mobilize neurotransmitter 
vesicles from the reserve pool to the readily releasable pool 
and thus facilitate subsequent vesicle release [78,79]. This 
calcium-dependent release has implications for short-term 
forms of plasticity such as paired pulse facilitation (PPF), a 
form of presynaptic plasticity. PPF involves residual calci-
um remaining in the presynaptic terminal following the ini-
tial stimulus, thus increasing the probability of neurotrans-
mitter release when a second stimulus in rapid temporal 
succession additively increases calcium influx into the pre-
synaptic terminal. ER stores may be a source for the residual 
calcium that contributes to PPF, and conditions that enhance 
CICR, such as PS mutations, may alter vesicle release 
probabilities. Post-tetanic potentiation (PTP) is another 
form of presynaptic plasticity that occurs following a high 
frequency stimulus. PTP reflects an enhancement of neuro-
transmitter release that leads to strengthening of the synapse 
for a brief period of time, typically on the order of seconds 
to minutes. PTP is also thought to involve residual calcium 
that results from voltage-gated calcium influx that accom-
panies a high frequency stimulus, and CICR recruited by 
voltage-gated calcium influx can increase residual calcium 
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[75,77,79].  
Postsynaptically, ER calcium initiates gene transcription 
[80], modulates membrane excitability and channel function 
[81,82], and integrates with synaptically evoked responses 
to encode long term plasticity changes in neuron function 
[83,84]. Dendritic spines are typically the initial loci of 
synaptic plasticity and contain several calcium channels 
such as NMDAR, AMPAR, VGCC, RyR and IP3R. Calci-
um in dendritic spines and dendrites regulates incoming 
electrochemical inputs for signal transmission through neu-
rons, and depending on the combination of channels re-
cruited, calcium influx can influence long-term changes in 
synaptic efficacy and plasticity. For example, NMDAR- 
mediated calcium entry into spines and dendrites is essential 
but not sufficient by itself for induction of LTP [79,86]. ER 
calcium stores can amplify the initial NMDAR-mediated 
signal and determine the polarity as well as input specificity 
of long-term plasticity. For example, blocking ER calcium 
stores eliminates LTD and results in a switch to LTP   
under the same stimulus conditions. Similarly, with an  
LTP-inducing stimulus, blocking ER stores reduces LTP 
while stimulating intracellular calcium release facilitates     
LTP [56,87,88].  
Certain forms of calcium-dependent synaptic plasticity, 
including LTP and LTD, are thought to underlie the cellu-
lar/molecular mechanisms of learning and memory [89–91]. 
This has been demonstrated in studies where NMDA cal-
cium channels or calcium-dependent kinases required for 
synaptic plasticity were manipulated, and learning and 
memory deficits resulted. Specifically, NMDA receptors are 
required not just for induction of LTP but also for estab-
lishing the duration and maintenance of LTP via activation 
of protein kinase Mζ (PKMζ), an isoform of protein kinase 
C. When blocking NMDA receptors or PKMζ , LTP is 
abolished and spatial learning, particularly the generation 
and maintenance of new place fields, is disrupted [92–96]. 
Similarly, rodents lacking the essential NR1 subunit of the 
NMDA receptor demonstrate disrupted place cell function 
and are unable to locate a hidden platform in the Morris 
water maze, suggesting that calcium-permeable channels 
are crucial in spatial learning and memory [97].  
Not only are changes in calcium levels important for 
transmission and plasticity induction, but the spatial and 
temporal patterns are critical encoding parameters as well. 
At synapses that support bidirectional plasticity, the induc-
tion of either LTP or LTD depends on the magnitude and 
temporal aspects of intracellular calcium dynamics-large 
and transient calcium rises are associated with LTP whereas 
modest and sustained calcium rises are associated with LTD 
[86,88,98]. Calcium/calmodulin-dependent protein kinase II 
(CAMKII) required for induction of LTP has low affinity 
for calcium and is activated when there are large but transi-
ent increases in postsynaptic calcium [99,100]. CAMKII 
together with protein kinase A (PKA) activate several 
downstream signaling cascades that drive AMPAR into the 
synapse [101–103] as well as CREB-dependent transcrip-
tion of proteins that sustain synaptic plasticity [104]. On the 
other hand, calcineurin or protein phosphatase 2B (PP2B) 
associated with LTD has a much higher affinity for calcium 
and is activated by modest and sustained increases in 
postsynaptic calcium [105,106]. Activation of calcineurin 
leads to dephosphorylation and internalization of AMPA 
receptors from the synapse and therefore results in a reduc-
tion in synaptic strength [107–108].  
The precise role of intracellular calcium stores in these 
processes is complex and may depend on the mechanism of 
calcium release from the ER (Figure 2). In neurons, the ER 
forms a continuous network that extends throughout the 
dendritic tree and into dendritic spines [109,110]. In CA1 
pyramidal neurons, the ER in the soma and dendritic shafts 
express both IP3R and RyR, while ER networks in distal 
processes and dendritic spine heads express a greater pro-
portion of RyR [80,112]. This suggests that calcium signal-
ing involving these individual receptors may support dif-
ferent roles in synaptic activity–the IP3Rs may be involved 
in gene transcription and protein synthesis in the soma, 
while RyRs may be better positioned to modulate incoming 
synaptic activity directly in dendritic spine heads or sub-
threshold signals that are confined to the isolated geometry 
of the spine heads, whereas IP3R activation may enter ex-
trasynaptic signaling pathways or require much higher 
threshold inputs. For example, in dendritic spines of hippo-
campal CA1 neurons, the NMDAR-mediated calcium signal 
is largely amplified by RyR-mediated CICR [78,113]. 
Blocking RyR with dantrolene obstructs the induction of 
LTP [56,114,115] as well as LTD (Chakroborty, un-
published findings), indicating that RyR-mediated ER cal-
cium is required for sustained plasticity and by association, 
memory and related cognitive functions. Additional evi-
dence for the fundamental role of RyR in synaptic plasticity 
emerges from studies using RyR knockout mice. For exam-
ple, RyR3 knockout mice show enhanced LTP which is 
independent of NMDAR-mediated mechanisms, but also 
exhibit impaired LTD [116]. The RyR3 is expressed in 
dendritic processes of hippocampal neurons [60], suggest-
ing that RyR3 isoform may function to suppress LTP and 
facilitate LTD. This may in turn serve to maintain the bal-
ance of excitation and inhibition that determines the overall 
stability of the synapse.  
There also appears to be functional overlap between RyR 
and IP3R-mediated calcium signaling and plasticity. Type 1 
IP3R knockout mice also demonstrate enhanced LTP, while 
LTD is not affected [117], suggesting that IP3R-sensitive 
ER calcium stores in general have an inhibitory role in LTP 
induction. Furthermore, IP3R-mediated calcium stores out- 
side dendritic spines may also suppress LTP in neighboring 
synapses, thus maintaining the input specificity that is 
characteristic of LTP. The differences in the effects of RyR 
and IP3R-mediated calcium signaling on synaptic plasticity, 
especially LTD, may reflect their anatomical and kinetic 
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Figure 2  Possible ER calcium-dependent plasticity mechanisms in axon terminals and dendritic spines. A, at the presynaptic axon terminal–① CICR can 
occur spontaneously to trigger synaptic vesicle release. During high frequency activity, CICR can be evoked by voltage-gated calcium influx to increase the 
residual calcium levels and release probability. ② ER calcium release is implicated in endocytosis of fused vesicles to the reserve pool and mobilization of 
vesicles to the readily releasable pool. B, At the postsynaptic terminal–① NMDAR-mediated calcium signal is amplified by RyR in dendritic spines and is 
probably necessary for homosynaptic plasticity. ② mGluR-mediated activation of the phospholipase C (PLC) pathway generates IP3. Subsequent activation 
of IP3Rs supports regenerative calcium waves, which may be involved in heterosynaptic plasticity and gene expression. (Reprinted with permission from  
Bardo et al., 2006). 
differences in coupling to different calcium stores. 
4  Effects of altered ER calcium on neurophysi-
ology: Implications for AD pathogenesis  
As implied in the preceding discussion, maintaining calcium 
homeostasis is crucial for synaptic activity and plasticity. 
Therefore, AD-linked mechanisms that interfere with cal-
cium signaling are important to investigate from both a dis-
ease-manifesting and therapeutic standpoint. For example, 
PS mutations result in RyR-mediated ER calcium signaling 
disruptions which occur prior to AD histopathology and 
persist through old age [32,46]. Previous studies in 
3×Tg-AD mice expressing mutant PS, APP and tau demon-
strate synaptic dysfunction coincident with the detection of 
intracellular Aβ deposits [44]. Yet prior to this stage, synap-
tic transmission appears normal. This is consistent with 
several studies in AD models suggesting that synaptic 
transmission is unaffected until amyloid deposits form 
[25,118]. Recent studies suggest that it is the soluble Aβ 
oligomers, and not insoluble amyloid plaques, that can 
cause synaptic dysfunction by disrupting intracellular cal-
cium homeostasis via the formation of calcium-permeable 
channels [119–122]. The increased cytosolic calcium levels 
due to Aβ-calcium channels not only increase metabolic 
stress but also contribute to a decrease in spine density and 
dystrophy and aberrant sprouting of dendrites, resulting in 
synaptic dysfunction [123–125]. These studies have con-
tributed to the view that Aβ is the underlying mechanism 
driving synaptic dysfunction. 
Yet, more detailed examination into the role of ER cal-
cium stores at early stages, prior to Aβ formation reveals 
pronounced deficits in baseline synaptic function that exist 
‘below the radar’ of detection. A recent study in young 
3×Tg-AD mice shows that dysregulated RyR-mediated ER 
calcium release alters hippocampal synaptic transmission 
and plasticity long before onset of AD histopathology (Fig-
ure 3) [56]. Under control conditions, basal synaptic trans-
mission, PPF and LTP appear similar between the non-
transgenic (NonTg) and AD mice. However, when the ER 
calcium contribution is manipulated, marked differences in 
the mechanisms underlying synaptic transmission and plas-
ticity now emerge. Under conditions when the RyRs are 
blocked and the enhanced CICR effect is suppressed, the 
AD neurons now demonstrate enhanced basal synaptic 
transmission and altered short and long term plasticity, with 
no effects seen in the NonTg mice. For example, the I/O 
function and PPF were increased in AD neurons but re-
mained unchanged in NonTg mice. This suggests that RyR- 
mediated calcium has a prominent inhibitory effect in basal 
synaptic transmission and presynaptic neurotransmitter re-
lease in the AD mice but has little role in NonTg mice under 
these conditions. There are additional aberrant contributions 
of ER calcium to synaptic plasticity as well in the AD mice. 
In NonTg mice, RyR blockade had no effect on baseline 
responses, though LTP expression was reduced, a finding 
consistent with existing literature [126]. Yet, in AD mice, 
blocking RyR with dantrolene decreased baseline responses 
and produced a shift from LTP to modest LTD. Further di-  
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vergent effects of ER calcium contribution to plasticity are 
seen with LTD-generating paradigms. RyR blockade en-
hances LTD in AD mice, while completely abolishing LTD 
in NonTg mice (Chakroborty, unpublished data). Therefore, 
without RyR blockade, there appears to be no differences in 
synaptic transmission or plasticity between young AD and 
NonTg mice, suggesting that compensatory mechanisms 
may mask these alterations early on in the disease process 
but may break down as the disease progresses. 
Consistent with these findings regarding the role of 
RyR-mediated calcium signaling in presynaptic transmis-
sion is another recent study utilizing conditional knockouts 
(cDKO) of PS1 and PS2 in either the pre or postsynaptic 
neurons at the Schaffer collateral synapse. Presenilins may 
modulate the role of presynaptic ER calcium in neurotrans-
mitter release and in induction of LTP, and loss of PS func-
tion may result in dysfunctional presynaptic neurotransmis-
sion via a RyR-dependent mechanism. Conditional inactiva-
tion of PS in CA3 neurons from PS cDKO mice reduces 
neurotransmitter release, synaptic facilitation and markedly 
impairs LTP, while conditional inactivation of PS in 
postsynaptic CA1 neurons does not affect these functions 
[126]. RyR blockade also decreases synaptic facilitation in 
CA3 neurons of PS cDKO mice, suggesting that presynaptic 
deficits are mediated by RyR-sensitive calcium stores. The-
se findings are further supported by earlier studies using 
PS1 knockout (KO) neurons as well as PS1 mutant mice. In 
these studies, PS1 mutant mice exhibit increased magnitude 
of LTP, while PS1 KO neurons are impaired in several cal-
cium-dependent aspects of synaptic transmission [127,128]. 
These neurons have altered synaptic connections reflected 
by changes in spine morphology and spine density, and they 
show a redistribution of proteins critical for synaptic func-
tion such as PSD-95 and AMPA receptors. There is also 
upregulation of the PKA-cAMP signaling pathway that reg-
ulates CREB-dependent transcription, suggesting that these 
changes may ultimately impair synaptic transmission and 
plasticity, and therefore memory processes, in a manner that 
reflects upstream calcium signaling alterations. 
5  Summary 
Intracellular calcium signaling is crucial to neuronal func-
tion, synaptic transmission, and plasticity mechanisms un-
derlying learning and memory. Owing to its ubiquitous role, 
sustained disruptions in calcium signaling have significant 
ramifications for neuronal and cognitive health over the 
lifetime of the organism. Current research suggests that the 
early disruptions in calcium homeostasis observed in AD 
incur pathogenic insults and are not inherent to normal ag-
ing [32,46,129]. Even though the direct mechanistic link 
between calcium dysregulation and AD pathology is still 
under investigation, one might surmise that calci-
um-mediated pathogenesis reflects a lifetime of gradually 
accumulating stressors and has multiple diffuse targets af-
fecting many cellular systems. Eventually, these stressors 
become part of a feedforward pathological cascade that later 
facilitate Aβ and tau deposition, ER and mitochondrial 
stress, loss of synapses, and ultimately, loss of memory 
(Figure 1) [32,129–131]. Therefore, considering calcium 
dyshomeostasis as an integral component of AD-linked 
synaptic pathology may yield new insights into the cellular 
mechanisms of cognitive deficits and offer novel therapeu-
tic interventions. 
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